Randy Hubbell

Randy Hubbell

Chief Executive Officer at
Carmell Regen Med Corp.
63 year
Health Technology
Consumer Services
Commercial Services

Profile

Randy Hubbell currently works at Carmell Regen Med Corp., as President, Chief Executive Officer & Director from 2016 and Neuraptive Therapeutics, Inc., as Director.
Mr. Hubbell also formerly worked at Longevity Health Holdings, Inc., as President, Chief Executive Officer & Director, Vasca, Inc., as Executive Director-Sales & Marketing in 2000, Cordis Cardiology, as Executive Director-Strategic Alliances, International Business Machines Corp., as Principal in 1993, Johnson & Johnson, as Principal, Boston Scientific Corp., as Principal in 1998, Enmedia, Inc., as Principal, Cardiva Medical, Inc., as Chief Commercial Officer, Johnson & Johnson Pharmaceutical Group, as Vice President-Global Strategic Marketing, and Ethicon Biosurgery Ireland, as Vice President-Global Strategic Marketing.
Mr. Hubbell received his Masters Business Admin degree from Loyola University New Orleans and undergraduate degree from Tulane University (Louisiana).

Randy Hubbell active positions

CompaniesPositionStart
Chief Executive Officer 2016-02-15
Director/Board Member -

Former positions of Randy Hubbell

CompaniesPositionEnd
LONGEVITY HEALTH HOLDINGS, INC. Chief Executive Officer 2023-08-30
Sales & Marketing 1999-12-31
BOSTON SCIENTIFIC CORPORATION Corporate Officer/Principal 1997-12-31
IBM Corporate Officer/Principal 1992-12-31
Enmedia, Inc.
Corporate Officer/Principal -
See the detail of Randy Hubbell's experience

Training of Randy Hubbell

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

87

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Technology Services

Health Technology

Health Technology

Health Technology

Enmedia, Inc.

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Johnson & Johnson Pharmaceutical Group

Ethicon Biosurgery Ireland

Commercial Services

Finance

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!